Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025 
California Governor Gavin Newsom Launches Review Into Alleged TikTok Content Suppression After U.S. Ownership Deal 
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership 
ANTA Sports to Acquire Major Stake in Puma in €1.5 Billion Deal, Signaling Strategic Revival 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Zijin Mining Shares Hit Record High on $4 Billion Allied Gold Acquisition 
ASML’s EUV Monopoly Powers the Global AI Chip Boom 
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
Embraer Targets Growth as Regional Jet Demand Surges Post-Pandemic 
Baker Hughes Reports 11% Rise in Q4 Adjusted Profit Driven by LNG Demand 
Ford and GM Near Financing Deal to Support First Brands Group During Bankruptcy 
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal 
SAN FRANCISCO, May 16, 2017 -- BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the UBS Global Healthcare Conference to be held in New York City from May 22nd to May 24th, 2017.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Tuesday, May 23rd at 2:00 p.m. Eastern Daylight Time.
About BioQ Pharma
BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, Galen Limited, and West Pharmaceutical Services.
BioQ Pharma Contact Information: Josh Kriesel President and CEO 415-336-6496 Ron Pauli Chief Financial Officer 415-889-7707 Media: Stephanie Carrington Integrated Corporate Relations, Inc (ICR) [email protected] 646-277-1282
